EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Predicting future exacerbations in uncontrolled asthma: A discovery/validation approach using large-scale clinical proteomics

Lisa M Jurak, Ian A Yang, Jodie L Simpson, Peter G Gibson, Michelle M Hill, John W Upham

Journal of Allergy and Clinical Immunology · 2025

DOI: 10.1016/j.jaci.2025.02.028 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Lisa M Jurak und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Queensland Frazer Institute, Woolloongabba, Australia. Hauptthemen laut MEDLINE: Asthma, Proteomics, Sputum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Queensland Cyber Infrastructure Foundation, NHMRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Exacerbations contribute significantly to the burden of asthma. Some individuals are predisposed to recurring exacerbations; however, the underlying mechanisms are not well understood. OBJECTIVE: Our aim was to generate a sputum protein signature associated with future exacerbations. METHOD: A total of 22 baseline sputum samples from the control (placebo control) arm of the AMAZES study were analyzed by using an optimized high-throughput mass spectrometry method. RESULTS: With use of a log fold change of at least 1.5 and a P value of .05 as cutoffs, univariate analysis identified 533 differentially abundant sputum proteins in participants with and without future exacerbations over the ensuing 48 weeks. A multivariate signature of 260 proteins for predicting future exacerbations was developed by using sparse partial least squares data analysis, which was partially able to predict (with an area under the receiver operating characteristic curve of 0.95 and an error rate of 0.41) those who would likely experience an exacerbation. Next, from sputum samples collected from an additional 123 participants, the 20 most influential proteins were selected for validation and quantification. After validation, 9 proteins were found to be linked to future exacerbation risk. The final model was able to predict future exacerbations with an area under the receiver operating characteristic curve of 0.77 and an error rate of 0.40. Pathway analysis revealed major themes associated with exacerbations, including inflammation, recruitment, and proliferation of immune cells. CONCLUSION: This study has identified, for what we believe is the first time, a sputum proteomic signature and pathways associated with future exacerbations, which will facilitate the discovery of new biomarkers and novel therapeutic targets in uncontrolled persistent asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaProteomicsSputumHumansMaleFemaleAdultMiddle AgedDisease ProgressionBiomarkers

Stichwörter der Autor:innen

Severe asthmaclinical proteomicsexacerbationsprotein signaturesputum

Substanzen

Biomarkers

Autor:innen und Institutionen

  • University of Queensland Frazer Institute, Woolloongabba, Australia.
  • UQ Thoracic Research Centre, the University of Queensland, Brisbane, Australia; Prince Charles Hospital, Brisbane, Australia.
  • University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia.
  • QIMR Berghofer Medical Research Institute, Herston, Australia; UQ Centre for Clinical Research, Herston, Australia.
  • University of Queensland Frazer Institute, Woolloongabba, Australia; Princess Alexandra Hospital, Woolloongabba, Australia. Electronic address: j.upham@uq.edu.au.

Förderung

  • Queensland Cyber Infrastructure Foundation
  • NHMRC

Zitieren

APA

Jurak, L. M., Yang, I. A., Simpson, J. L., Gibson, P. G., Hill, M. M., & Upham, J. W. (2025). Predicting future exacerbations in uncontrolled asthma: A discovery/validation approach using large-scale clinical proteomics. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.02.028

Vancouver

Jurak LM, Yang IA, Simpson JL, Gibson PG, Hill MM, Upham JW. Predicting future exacerbations in uncontrolled asthma: A discovery/validation approach using large-scale clinical proteomics. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2025.02.028

BibTeX
@article{Jurak2025,
  author = {Jurak, Lisa M and Yang, Ian A and Simpson, Jodie L and Gibson, Peter G and Hill, Michelle M and Upham, John W},
  title = {Predicting future exacerbations in uncontrolled asthma: A discovery/validation approach using large-scale clinical proteomics},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2025},
  doi = {10.1016/j.jaci.2025.02.028}
}
Kostenlos starten →